Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

<p>Newly Launched CGMP Manufacturing Suites Undergoing Final Environmental Monitoring and Performance Qualification with Grand Opening Planned for January 2024 Completion of CGT Facility Brings Company’s Total Revenue Generating Capacity to up to Approximately $400 Million Annually TUSTIN, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/avid-bioservices-completes-construction-of-new-world-class-cell-and-gene-therapy-development-and-manufacturing-facility/">Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>